Ibrahim, Hany M <br/><br/>
Development of meloxicam in situ implant formulation by quality by design principle.  [electronic resource] 

 -  Drug development and industrial pharmacy  Jan 2014 
 - 66-73 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1520-5762 
<br/><br/><label>Standard No.: </label>10.3109/03639045.2012.746360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Area Under Curve<br/>Chemistry, Pharmaceutical--methods<br/>Drug Carriers--chemistry<br/>Drug Compounding--methods<br/>Drug Implants<br/>Gels<br/>Inhibitory Concentration 50<br/>Lactic Acid--chemistry<br/>Male<br/>Meloxicam<br/>Microscopy, Electron, Scanning<br/>Polyglycolic Acid--chemistry<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Pyrrolidinones--chemistry<br/>Rats<br/>Rats, Sprague-Dawley<br/>Spectroscopy, Fourier Transform Infrared<br/>Thiazines--administration & dosage<br/>Thiazoles--administration & dosage<br/>Viscosity<br/>X-Ray Diffraction